Agilon Health (AGL) Capital Expenditures (2020 - 2026)

Agilon Health (AGL) has 7 years of Capital Expenditures data on file, last reported at $3.1 million in Q1 2026.

• Quarterly Capital Expenditures fell 19.43% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 million (down 10.51% YoY) and the FY2025 annual result came in at $13.2 million, changed 0.07% from the prior year.
• Capital Expenditures rose to $3.1 million in Q1 2026, from $3.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $4.5 million in Q2 2022 to a low of $3.0 million in Q4 2025.
• A 5-year average of $3.6 million and a median of $3.5 million in 2022 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2022 — Capital Expenditures soared 2174.72% — and 2026, when it slipped 19.43%.
• Tracing AGL's Capital Expenditures over 5 years: stood at $3.5 million in 2022, then rose by 12.7% to $3.9 million in 2023, then slipped by 16.94% to $3.3 million in 2024, then retreated by 9.12% to $3.0 million in 2025, then gained by 4.48% to $3.1 million in 2026.
• The last three Capital Expenditures figures came in at $3.1 million (Q1 2026), $3.0 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.